N'-羟基-2-甲基-1,3-噻唑-4-甲脒 | 263385-95-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: N'-羟基-2-甲基-1,3-噻唑-4-甲脒
• 英文名称: 4-(2-methylthiazole)-amidoxime
• 英文别名: 2-methyl-thiazole-4-amidoxime；4-Thiazolecarboximidamide,n-hydroxy-2-methyl-；N'-hydroxy-2-methyl-1,3-thiazole-4-carboximidamide
• CAS: 263385-95-1
• 化学式: C₅H₇N₃OS
• 分子量: 157.196
• InChiKey: SLZGQHLQOOLDIA-UHFFFAOYSA-N

物化性质

• 沸点：
  289.0±32.0 °C(Predicted)
• 密度：
  1.54±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  99.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N'-羟基-2-甲基-1,3-噻唑-4-甲脒 、 3-氯噻吩-2-甲酰氯 以18.2 mg (40%)的产率得到5-(3-Chloro-thiophen-2-yl)-3-(2-methyl-thiazol-4-yl)-[1,2,4]-oxadiazole
  参考文献：
  名称：

  Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

  摘要：

  本发明涉及取代的3-芳基-5-芳基-[1,2,4]-噁二唑及其类似物，由以下式I表示： 1 其中Ar1，Ar3，A，B和D在此处定义。本发明还涉及发现具有式I的化合物是caspase的激活剂和凋亡诱导剂。因此，本发明的caspase激活剂和凋亡诱导剂可用于诱导在各种临床病况中发生未受控制的异常细胞生长和扩散的细胞死亡。

  公开号：

  US20030045546A1

文献信息

• Substituted Acyloxyamidines as HCV NS3/4A Inhibitors
  申请人：ViroCura Therapeutics, Inc.

  公开号：US20150133495A1

  公开（公告）日：2015-05-14

  Disclosed herein is a compound of Formula I or a pharmaceutically acceptable salt thereof, in which A, G, R 1 and R 2 are as defined herein. The compounds and pharmaceutical compositions of the compounds are suitable for the treatment of HCV infection in mammals and are also useful to modulate or inhibit NS3/4 dimerization.

  本文公开了一种I式化合物或其药学上可接受的盐，其中A、G、R1和R2的定义如本文所述。这些化合物及其制剂适用于哺乳动物HCV感染的治疗，并且也有用于调节或抑制NS3/4二聚体化的作用。
• HETEROARYL-SUBSTITUTED PIPERIDINES
  申请人：Heimbach Dirk

  公开号：US20090306139A1

  公开（公告）日：2009-12-10

  The invention relates to novel heteroaryl-substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular diseases and tumour diseases.

  本发明涉及新型杂环芳基取代哌啶，其制备过程，其用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物，特别是心血管疾病和肿瘤疾病。
• Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：Cytovia, Inc.

  公开号：US07435750B2

  公开（公告）日：2008-10-14

  The present invention is directed to substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs thereof, represented by the Formula I: wherein Ar1, Ar3, A, B and D are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明涉及被公式I所代表的取代的3-芳基-5-芳基-[1,2,4]-噁二唑及其类似物，其中Ar1、Ar3、A、B和D在此被定义。本发明还涉及发现具有公式I的化合物是caspase的激活剂和凋亡诱导剂。因此，本发明的caspase激活剂和凋亡诱导剂可用于在各种临床病症中诱导细胞死亡，其中出现了异常细胞的不受控制的生长和扩散。
• Heteroaryl-substituted piperidines
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US08119663B2

  公开（公告）日：2012-02-21

  The invention relates to novel heteroaryl-substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular diseases and tumor diseases.

  本发明涉及新型杂环芳基取代哌啶，其制备过程，以及它们用于治疗和/或预防疾病的用途，以及用于制备治疗和/或预防疾病的药物，特别是心血管疾病和肿瘤疾病。
• New compounds, pharmaceutical compositions and uses thereof
  申请人：NOSSE Bernd

  公开号：US20130065906A1

  公开（公告）日：2013-03-14

  The present invention relates to compounds of general formula I, wherein the groups R 1 , L P , L Q , Ar, m and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.

  本发明涉及一般式I的化合物，其中R1、LP、LQ、Ar、m和n的定义如申请书所述，具有有价值的药理特性，特别是能够结合GPR119受体并调节其活性。